Negative pressure wound therapy sales will grow through 2036, led by standalone NPWT devices at 34.4% of the product segment in 2026, driven by increasing clinical adoption and expanding procedural volume across hospital systems. The market was valued at USD 7.08 billion in 2025 and is expected to be worth USD 11.98 billion by 2036.